Allspring Global Investments Holdings LLC Grows Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Allspring Global Investments Holdings LLC boosted its position in Phibro Animal Health Co. (NASDAQ:PAHC – Get Rating) by 406.0% in the 3rd quarter, Holdings Channel reports. The fund owned 70,303 shares of the company’s stock after purchasing an additional 56,410 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Phibro Animal Health were worth $934,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. KBC Group NV purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $30,000. Gladius Capital Management LP purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $68,000. Lazard Asset Management LLC purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $122,000. Connors Investor Services Inc. purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $191,000. Finally, M&T Bank Corp purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $227,000. 49.21% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $15.33 on Friday. The company has a current ratio of 3.30, a quick ratio of 1.68 and a debt-to-equity ratio of 1.72. The firm has a market capitalization of $620.93 million, a price-to-earnings ratio of 13.33, a PEG ratio of 8.06 and a beta of 0.53. The firm’s fifty day simple moving average is $13.29 and its 200 day simple moving average is $15.15. Phibro Animal Health Co. has a twelve month low of $11.75 and a twelve month high of $22.16.

Phibro Animal Health (NASDAQ:PAHC – Get Rating) last issued its quarterly earnings data on Wednesday, November 9th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.05). Phibro Animal Health had a return on equity of 19.90% and a net margin of 4.85%. The firm had revenue of $232.50 million during the quarter, compared to analyst estimates of $224.19 million. As a group, equities research analysts expect that Phibro Animal Health Co. will post 1.22 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 21st. Shareholders of record on Wednesday, November 30th were issued a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, November 29th. This represents a $0.48 dividend on an annualized basis and a yield of 3.13%. Phibro Animal Health’s dividend payout ratio is currently 41.74%.

Analyst Ratings Changes

Several brokerages have recently issued reports on PAHC. StockNews.com cut shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Friday, November 11th. Morgan Stanley reduced their target price on shares of Phibro Animal Health from $21.00 to $20.00 and set an “equal weight” rating on the stock in a report on Thursday, November 10th. Finally, Roth Capital started coverage on shares of Phibro Animal Health in a report on Wednesday, December 21st. They set a “buy” rating and a $18.00 target price on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $18.33.

Phibro Animal Health Profile

(Get Rating)

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.